Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06606119 · ClinicalTrials.gov registry record

The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma

A clinical trial of Critical Illness and Trauma, sponsored by University of Florida.

Recruiting
Registry status
275
Enrollment target
3
Study locations

NCT06606119: Recruiting study of Critical Illness and Trauma, sponsored by University of Florida.

NCT06606119 is a study of Critical Illness and Trauma that is actively recruiting participants, run by University of Florida. The registered enrollment target is 275 participants, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06606119, a study of Critical Illness and Trauma, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
275 participants
Enrollment target
3
Study locations

Study Summary

Traumatic injury followed by critical illness provokes pathophysiologic changes in the bone marrow and the gut that contribute to persistent anemia and changes in the microbiome which significantly impact long-term recovery. This project will define the interactions between the stress, chronic inflammation, bone marrow dysfunction, and an altered microbiome which will provide a strong foundation for future clinical interventions to help improve outcomes following severe trauma.

Primary Outcome

The impact of the severity and duration of catecholamine secretion on the cellular biology of HSPCs and erythroid progenitor cells requires further detailed evaluation. At each stage of proliferation and differentiation, there is a complex interaction of cytokines, transcription factors, post-translational modification of histones, and miRs. Single-cell RNA-seq technologies using a novel second generation multi-omics technology, CITE-seq, will be used for identification of isolated HSPCs and ery

Interventions

  • OTHER Data and tissue collection

Study Locations (3)

Florida

  • UF Academic Research Building - Gainesville
  • UF Health at Shands Hospital - Gainesville
  • UF Laboratory of Inflammation Biology and Surgical Science and Shands Hospital at UF - Gainesville

Trial Details

FieldValue
Enrollment Target 275 participants
Start Date 2025-01-24
Est. Completion 2028-10-01
University of Florida

1,106 total trials

What NCT06606119 shows while recruiting

NCT06606119 is an observational study that tracks outcomes without assigning an intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (91% lower).

The record links to 6 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which Data and tissue collection is the first listed.

NCT06606119 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06606119 about?

NCT06606119 is a clinical study titled "The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma". Traumatic injury followed by critical illness provokes pathophysiologic changes in the bone marrow and the gut that contribute to persistent anemia and changes in the microbiome which significantly impact long-term recovery. This project will define the interactions between the stress, chronic infla...

What is the current status of trial NCT06606119?

This trial is currently recruiting. The enrollment target is 275 participants. The study started on 2025-01-24. Estimated completion is 2028-10-01.

What conditions does trial NCT06606119 study?

This clinical trial studies the following conditions: Critical Illness, Trauma, Trauma Injury, Microbiome, Acute Blood Loss Anemia.

What interventions are being tested in trial NCT06606119?

The interventions under investigation include: Data and tissue collection (OTHER).

Who is sponsoring clinical trial NCT06606119?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06606119 being conducted?

This trial has 3 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06606119's enrollment target sits among peer trials

275 43rd of 91 higher than 49 of 91 other Critical Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269190 · 275 participants · NA

    Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery

  • NCT01900132 · 275 participants · NA

    Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

  • NCT04104776 · 275 participants · Phase 1

    A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • NCT04765150 · 275 participants

    Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06606119, the US trial registry maintained by the National Library of Medicine. NCT06606119 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.